Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9023810
APP PUB NO 20110274778A1
SERIAL NO

12929684

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of a compound comprising D-mannoheptulose and/or perseitol for producing a drug for treating and/or preventing diseases related to the modification of an innate and/or acquired immunity by increasing the production of antimicrobial peptides, preferably hBD-2 without inducing inflammatory reactions, irritation or intolerance. Said compound can also comprise a peptidic avocado extract an/or a peptidic lupin extract.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LABORATORIES EXPANSCIENCECOURBEVOIE CEDEX

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bredif, Stéphanie Chaudon, FR 11 51
Msika, Philippe Versailles, FR 81 363
Paul, François Montgauch, FR 8 52
Piccardi, Nathalie Arceau, FR 36 144
Piccirilli, Antoine Villennes sur Seine, FR 57 342

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 5, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00